Loading the map…
Manufacture of pharmaceutical preparations · London
Ascend Advanced Therapies
Ascend Advanced Therapies Limited
Private limited company registered in London, classed under “Manufacture of pharmaceutical preparations” and 1 other activity.
Headline figures
FY to Dec 2024 · As filed (group accounts)
Turnover
For subscribers
Profit after tax
−£22.4m
Net assets
For subscribers
Cash
For subscribers
Employees
For subscribers
Retained reserves
For subscribers
What the numbers say
3 findings from the figures, in plain English
Written by rules from the figures on this page. Not a forecast or a credit opinion.
History
| £ | 2023 | 2024 |
|---|---|---|
| Profit after tax | −£22.4m | |
| Turnover | ||
| Net assets | ||
| Cash | ||
| Employees | ||
| Retained reserves |
Every figure for all 2 years
“—” means we did not find the figure in a source; it is never filled with an estimate.
Balance sheet and ratios
From the filed balance sheets · £
| Balance sheet | 2023 | 2024 |
|---|---|---|
| Fixed assets | ||
| Current assets | ||
| of which debtors | ||
| of which cash | ||
| Creditors due within a year | ||
| Net current assets | ||
| Net assets | ||
| Ratios | ||
| Return on equityProfit after tax as a share of net assets | ||
| Current ratioCurrent assets for every £1 owed within a year | ||
| Cash ratioCash for every £1 owed within a year | ||
| Creditors to assetsEverything owed to creditors as a share of fixed plus current assets | ||
7 balance-sheet lines and 4 ratios, every year
A ratio appears only for years where every line it needs was filed. Lines are as tagged in the accounts; nothing is added up or estimated.
Timeline
Checked 2026-10-27
- AccountsGroup of companies' accounts made up to 31 December 2024
- AddressRegistered office address changed from 3rd Floor 1 Ashley Road Altrincham Cheshire WA14 2DT United Kingdom to Suite 1, 7th Floor 50 Broadway London SW1H 0DB on 13 February 2026
- DirectorsAppointment of Mr per Fredrik Thorell as a director on 20 January 2026
- DirectorsTermination of appointment of Michael Anthony Stella as a director on 20 January 2026
- DirectorsTermination of appointment of Oakwood Corporate Secretary Limited as a secretary on 22 January 2026
- NoticeCompulsory strike-off action has been discontinued
- NoticeFirst Gazette notice for compulsory strike-off
- DirectorsTermination of appointment of Errett Wesley Mcconnell Iii as a director on 3 June 2025
- FilingResolutions (and 3 more like it since 1 March 2023)
- DirectorsTermination of appointment of Justin Wesley Kern as a director on 6 November 2024
- DirectorsTermination of appointment of Fred Cohen as a director on 6 November 2024
- DirectorsTermination of appointment of Andrey Kozlov as a director on 6 November 2024
26 earlier
- DirectorsTermination of appointment of Balaji Muralidhar as a director on 6 November 2024
- DirectorsTermination of appointment of Andrew Sinclair as a director on 6 November 2024
- DirectorsTermination of appointment of Michael Charles Beecham as a director on 6 November 2024
- DirectorsTermination of appointment of Timothy Michael Funnell as a director on 6 November 2024
- DirectorsAppointment of Errett Wesley Mcconnell Iii as a director on 6 November 2024
- FilingMemorandum and Articles of Association (and 4 more like it since 6 March 2023)
- SharesCancellation of shares. Statement of capital on 6 November 2024 · GBP 1,215.40341 (and 3 more like it since 17 January 2023)
- SharesPurchase of own shares (and 3 more like it since 17 January 2023)
- SharesParticulars of variation of rights attached to shares (and 17 more like it since 17 January 2023)
- SharesChange of share class name or designation (and 17 more like it since 18 January 2023)
- DirectorsAppointment of Justin Wesley Kern as a director on 22 July 2024
- DirectorsTermination of appointment of Eric Norio Shiozaki as a director on 22 July 2024
- AccountsGroup of companies' accounts made up to 31 December 2023
- SharesStatement of capital following an allotment of shares on 30 May 2024 · GBP 1,215.82843 (and 8 more like it since 16 December 2022)
- NameCertificate of change of name
- DirectorsDirector's details changed for Mr Andrey Kozlov on 11 October 2023
- ChargesRegistration of charge 134710830002, created on 21 August 2023
- ChargesRegistration of charge 134710830001, created on 21 August 2023
- OwnershipNotification of a person with significant control statement
- OwnershipCessation of Fred Cohen as a person with significant control on 7 February 2023
- OwnershipCessation of Charles Conn as a person with significant control on 7 February 2023
- AccountsAccounts for a small company made up to 31 December 2022
- DirectorsAppointment of Michael Anthony Stella as a director on 1 May 2023
- DirectorsAppointment of Mr Andrey Kozlov as a director on 20 March 2023
- DirectorsTermination of appointment of Andrew Paul May as a director on 15 February 2023
- DirectorsAppointment of Dr Balaji Muralidhar as a director on 7 February 2023
- Directors
From the Companies House filing history. Routine confirmation statements are left out, and a run of the same filing is shown once.
Questions people ask
›What does Ascend Advanced Therapies do?
Private limited company registered in London, classed under “Manufacture of pharmaceutical preparations” and 1 other activity.
›How much turnover does Ascend Advanced Therapies make?
Answered in the full report
›Is Ascend Advanced Therapies profitable?
No: it made a loss after tax of £22.4m in the year to 31 December 2024, its latest filed accounts.
›How many people work at Ascend Advanced Therapies?
Answered in the full report
›Who runs and owns Ascend Advanced Therapies?
Its directors are Per Fredrik Thorell. Its owners are shown to subscribers.
›Where is Ascend Advanced Therapies based?
Its registered office is Suite 1, 7th Floor, 50 Broadway, London, SW1H 0DB, in London.
›When was Ascend Advanced Therapies founded?
Ascend Advanced Therapies Limited was incorporated on 22 June 2021.
›Is Ascend Advanced Therapies still trading?
The register lists Ascend Advanced Therapies Limited as active.